.
MergerLinks Header Logo

New Deal


Announced

Completed

Maverix Medical completed the acquisition of Cirrus Bio.

Synopsis

Maverix Medical, a dedicated lung cancer platform, completed the acquisition of Cirrus Bio, a company that develops and brings to market multiomic solutions for the diagnosis and management of diseases. Financial terms were not disclosed. "Lung cancer remains the largest cancer killer, by far. The only way to improve survival rates for this extremely aggressive disease is to catch it early and act decisively. This acquisition gives Maverix unparalleled technology, talent, and expertise in early cancer detection, and will serve as the foundation for a broader diagnostic portfolio with the potential to transform lung cancer care," Duke Rohlen, Maverix Medical Executive Chairman.

Show Details & Financials

Market Context

Sort

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US